THE DETECTION OF CLONAL PROLIFERATION IN GRANULAR LYMPHOCYTE-PROLIFERATIVE DISORDERS OF NATURAL-KILLER-CELL LINEAGE

被引：42

作者：

SHIMODAIRA, S

ISHIDA, F

KOBAYASHI, H

MAHBUB, B

KAWAHA, K

KITANO, K

机构：

[1] OSAKA MED CTR,IZUMI,OSAKA,JAPAN

[2] RES INST MATERNAL & CHILD HLTH,IZUMI,OSAKA,JAPAN

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1995年 / 90卷 / 03期

关键词：

GLPD; CLONALITY; CHROMOSOMAL ANALYSIS; EBV DNA ANALYSIS; TCR GENE REARRANGEMENT;

D O I：

10.1111/j.1365-2141.1995.tb05587.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The clonal proliferation of large granular lymphocytes can be detected in patients with T-cell-lineage granular lymphocyte-proliferative disorders (T-GLPD) by Southern blotting T-cell receptor genes. However, this cannot be applied to patients with natural killer-cell-lineage GLPD (NK-GLPD) as it lacks a clonal marker. We therefore investigated the use of two other diagnostic techniques in evaluating clonal proliferation in Japanese patients with NK-GLPD (n=4) and T-GLPD (n=3) by chromosomal analysis of peripheral blood mononuclear cells (PBMC) stimulated with either interleukin-2 or phytohaemagglutinin, and Epstein-Barr viral (EBV) genomic DNA analysis, Chromosomal analysis revealed abnormal karyotypes in the PBMC of three of four patients with NK-GLPD, whereas EBV analysis showed a monoclonal terminal configuration in the PBMC in the fourth patient. Southern blots revealed rearrangements of the TCR genes in all three patients with T-GLPD but in none of those with NK-GLPD. It is suggested that these methods may be useful in detecting the abnormal proliferation of large granular lymphocytes in NK-GLPD.

引用

页码：578 / 584

页数：7

共 29 条

[21]

Oshimi K., Yamada O., Kaneko T., Nishinarita S., Lizuka Y., Urabe A., Mamori T., Asano S., Takahashi S., Hattori M., Naohara T., Ohira Y., Togawa A., Masuda Y., Okubo Y., Furusawa S., Sakamoto S., Omine M., Mori M., Tatsumi E., Mizoguchi H., Laboratory findings and clinical courses of 33 patients with granular lymphocyte‐proliferative disorders, Leukemia, 7, pp. 782-788, (1993)

[22]

Pandolfi F., Loughran T.P., Starkebaum G., Chisesi T., Barbui T., Chan W.C., Brouet J.C., De Rossi G., McKenna R.W., Salsano F., Herrmann F., van Oostveen J.W., Schlimok G., Cafaro A., Zambello R., Rodriguez M.C.G., Geisler C.H., Pizzolo G., Steis R.G., Brisbane J.U., Kadin M.E., Mantovani A., Tagawa S., Fauci A.S., Gastl G., Palutke M., Proctor S.J., Pross H.F., Mancini P., Aiuti F., Semenzato G., Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes: a multi

[23]

Phillips J.H., Lanier L.L., Dissection of the lymphokine‐activated killer phenomenon: relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis, Journal of Experimental Medicine, 164, pp. 814-825, (1986)

[24]

Raab-Traub N., Flynn K., The structure of the termini of the Epstein‐Barr virus as a marker of clonal cellular proliferation, Cell, 47, pp. 883-889, (1986)

[25]

Semenzato G., Pandolfi F., Chisesi T., De Rossi G., Pizzolo G., Zembello R., Trentis L., Agostini C., Dini E., Vespignani M., Cafaro A., Pasqualetti D., Giubellino M.C., Migone N., Foa R., The lymphoproliferative disease of granular lymphocytes: a heterogeneous disorder ranging from indolent to aggressive conditions, Cancer, 60, pp. 2971-2978, (1987)

[26]

Taniwaki M., Tagawa S., Nishigaki H., Horiike S., Misawa S., Shimazaki C., Maekawa T., Fujii H., Kitani T., Abe T., Chromosomal abnormalities define clonal proliferation in CD3‐large granular lymphocyte leukemia, American Journal of Hematology, 33, pp. 32-38, (1990)

[27]

Tefferi A., Greipp P.R., Leibson P.J., Thibodeau S.N., Demonstration of clonality, by X‐linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide, Leukemia, 6, pp. 477-480, (1992)

[28]

Tefferi A., Li C.-Y., Witzing T.E., Dhodapkar M.V., Okuno S.H., Phyliky R.L., Chronic natural killer cell lymphocytosis: a descriptive clinical study, Blood, 84, pp. 2721-2725, (1994)

[29]

Tsudo M., Goldman C.K., Bongiovanni K.F., Chan W.C., Winton E.F., Yagiat M., Grimm E.A., Waldmann T.A., The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells, Proceedings of the National Academy of Sciences of the United States of America, 84, pp. 5394-5398, (1987)

← 1 2 3 →